Showing results (21-30 of 128) with videos related to
Sort By:
Pageof 13
Pediatric Blood & Cancer|January 24, 2024
Safety and tolerability of intravenous aprepitant and fosaprepitant in children with cancer: A retrospective, single-center reviewSrivarshini Kanukollu, Krisoula Spatz, Jessica A Lavery, et al.AJR. American Journal of Roentgenology|April 7, 2021
Diagnostic and Prognostic Utility of 18F-FDG PET/CT in Recurrent Salivary Gland CancersReiko Nakajima, Snehal G Patel, Nora Katabi, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 8, 2021
18F-FDG PET/CT for Posttreatment Surveillance Imaging of Patients with Stage III Merkel Cell CarcinomaSonia Mahajan, Christopher A Barker, Audrey Mauguen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2022
Interim Analysis of a Prospective Validation of 2 Blood-Based Genomic Assessments (PPQ and NETest) to Determine the Clinical Efficacy of 177Lu-DOTATATE in Neuroendocrine TumorsLisa Bodei, Nitya Raj, Richard K Do, et al.Journal of the American Statistical Association|June 13, 2017
Defining Cancer Subtypes With Distinctive Etiologic Profiles: An Application to the Epidemiology of MelanomaAudrey Mauguen, Emily C Zabor, Nancy E Thomas, et al.Blood Advances|April 29, 2020
Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic informationReiko Nakajima, Alison J Moskowitz, Laure Michaud, et al.Cancer Epidemiology|February 8, 2022
Socioeconomic status and its relation with breast cancer recurrence and survival in young women in the NetherlandsMarissa C van Maaren, Bernard Rachet, Gabe S Sonke, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 19, 2020
Head-to-Head Evaluation of 18F-FES and 18F-FDG PET/CT in Metastatic Invasive Lobular Breast CancerGary A Ulaner, Komal Jhaveri, Sarat Chandarlapaty, et al.The Pediatric Infectious Disease Journal|January 8, 2024
Retrospective Evaluation of Cystatin C as a Measure of Renal Function in Pediatric Hematopoietic Stem Cell Transplant Patients Receiving Foscarnet for Cytomegalovirus ReactivationLogan R Pickett, Nicole P Daukshus, Christine Camacho-Bydume, et al.Journal of Hematology & Oncology|November 27, 2025
Naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for primary refractory high-risk neuroblastoma: results of a phase I/II trialBrian H Kushner, Shakeel Modak, Audrey Mauguen, et al.Pageof 13